tiprankstipranks
Advertisement
Advertisement

GILD Stock Latest News

Gilead: Buy Rating Reiterated as Emvistegrast I&I Upside Keeps $168 Price Target Unchanged
RatingsGilead: Buy Rating Reiterated as Emvistegrast I&I Upside Keeps $168 Price Target Unchanged
19h ago
GILD
Gilead announces launch of lenacapavir in South Africa
PremiumThe Fly
Gilead announces launch of lenacapavir in South Africa
1d ago
GILD
Gilead’s IDEAL PBC Trial Reaches Key Milestone, Setting Up a New Liver Disease Catalyst
PremiumCompany Announcements
Gilead’s IDEAL PBC Trial Reaches Key Milestone, Setting Up a New Liver Disease Catalyst
2d ago
GILD
Gilead announces results from Phase 3 study of Livdelzi
PremiumThe Fly
Gilead announces results from Phase 3 study of Livdelzi
4d ago
GILD
Gilead’s Lenacapavir PrEP Study: Real-World Data That Could Reshape the HIV Prevention Market
PremiumCompany Announcements
Gilead’s Lenacapavir PrEP Study: Real-World Data That Could Reshape the HIV Prevention Market
8d ago
GILD
Gilead presents new Livdelzi data at EASL congress
PremiumThe FlyGilead presents new Livdelzi data at EASL congress
10d ago
GILD
SM, Casey’s, Gilead, Dominion, Insulet Trending With Analysts
Premium
Weekend Updates
SM, Casey’s, Gilead, Dominion, Insulet Trending With Analysts
14d ago
D
SM
Citizens biotech analysts hold a dinnermeeting at ASCO
Premium
The Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
15d ago
AZN
LLY
FDA approves Gilead’s Hepcludex injection to treat chronic HDV infection
PremiumThe Fly
FDA approves Gilead’s Hepcludex injection to treat chronic HDV infection
15d ago
GILD
Gilead receives positive CHMP opinion for Trodelvy in TNBC
PremiumThe Fly
Gilead receives positive CHMP opinion for Trodelvy in TNBC
15d ago
GILD
Gilead completes acquisition of Tubulis for $3.15B upfront
PremiumThe Fly
Gilead completes acquisition of Tubulis for $3.15B upfront
16d ago
GILD
Gilead renews five-year collaboration with World Health Organization
PremiumThe Fly
Gilead renews five-year collaboration with World Health Organization
16d ago
GILD
Gilead Sciences Launches New $3 Billion Senior Notes
PremiumCompany AnnouncementsGilead Sciences Launches New $3 Billion Senior Notes
17d ago
8K
GILD
Cigna downgraded, Humana upgraded: Wall Street’s top analyst calls
Premium
The Fly
Cigna downgraded, Humana upgraded: Wall Street’s top analyst calls
17d ago
D
BJ
RBC Capital remains ‘conservative’ on Gilead’s Trodelvy and Yeztugo
Premium
The Fly
RBC Capital remains ‘conservative’ on Gilead’s Trodelvy and Yeztugo
17d ago
GILD
Gilead upgraded to Buy at Maxim on approaching growth drivers, valuation
PremiumThe Fly
Gilead upgraded to Buy at Maxim on approaching growth drivers, valuation
17d ago
GILD
Gilead upgraded to Buy from Hold at Maxim
PremiumThe Fly
Gilead upgraded to Buy from Hold at Maxim
17d ago
GILD
Gilead Sciences Earnings Call Highlights Growth, Deal Drag
PremiumCompany Announcements
Gilead Sciences Earnings Call Highlights Growth, Deal Drag
17d ago
GILD
Gilead to present new data on PBC, viral hepatitis at EASL 2026
PremiumThe Fly
Gilead to present new data on PBC, viral hepatitis at EASL 2026
24d ago
GILD
Gilead price target lowered to $168 from $175 at Morgan Stanley
PremiumThe FlyGilead price target lowered to $168 from $175 at Morgan Stanley
27d ago
GILD
Analyst Reiterates Buy on Gilead as Strong Q1 and Upgraded Yeztugo Outlook Offset EPS Guidance Cut Despite Price Target Reduction to $168
Premium
Ratings
Analyst Reiterates Buy on Gilead as Strong Q1 and Upgraded Yeztugo Outlook Offset EPS Guidance Cut Despite Price Target Reduction to $168
27d ago
GILD
Gilead Sciences Balances Strong Growth With EPS Hit
Premium
Company Announcements
Gilead Sciences Balances Strong Growth With EPS Hit
29d ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >